Back to Search
Start Over
Influence of the healthcare pathway on the outcome of patients with infective endocarditis
- Source :
- European Heart Journal: Acute Cardiovascular Care, European Heart Journal: Acute Cardiovascular Care, 2022, 11 (9), pp.672-681. ⟨10.1093/ehjacc/zuac088⟩
- Publication Year :
- 2022
- Publisher :
- Oxford University Press (OUP), 2022.
-
Abstract
- Aims To determine the prognosis of patients treated for infective endocarditis (IE) according to their healthcare pathway. To assess how the ESC guidelines are implemented concerning the performance of transoesophageal echocardiography, the use of antibiotic therapy, and the performance of valve surgery; and to compare the epidemiological profile of IE according to the type of centres in which the patients are hospitalized. Methods and results In a prospective multicentric study including 22 hospitals in the South-East of France, 342 patients were classified into three groups according to their healthcare pathway: 119 patients diagnosed and taken care entirely in a reference centre or hospital with cardiac surgery [Referral Center (RC) group], 111 patients diagnosed and initially taken care in a non-RC (NRC), then referred in a centre including cardiac surgery [transferred to the Referral Center (TRC) group] and 112 patients totally taken care in the NRC (NRC group). One-year mortality was 26% (88 deaths) and was not significantly different between Groups 1 and 2 (20 vs. 21%, P = 0.83). Patients in the NRC group had a higher mortality (37%) compared with patients in the RC and TRC groups (P Conclusion Prognosis of patients with IE is influenced by their healthcare pathway. Patients treated exclusively in NRC have a worse prognosis than patients treated in referral or surgical centres.
- Subjects :
- MESH: Endocarditis
MESH: Humans
Endocarditis
Referral centre
MESH: Delivery of Health Care
MESH: Retrospective Studies
Endocarditis, Bacterial
General Medicine
Critical Care and Intensive Care Medicine
MESH: Prospective Studies
Anti-Bacterial Agents
[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
MESH: Anti-Bacterial Agents
Humans
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Hospital Mortality
Prospective Studies
MESH: Endocarditis, Bacterial
MESH: Hospital Mortality
Mortality
Cardiology and Cardiovascular Medicine
Delivery of Health Care
Retrospective Studies
Healthcare pathway
Subjects
Details
- ISSN :
- 20488734 and 20488726
- Volume :
- 11
- Database :
- OpenAIRE
- Journal :
- European Heart Journal. Acute Cardiovascular Care
- Accession number :
- edsair.doi.dedup.....2dee3bb2fab90d8fbd95cdca9ae0085c